A new drug developed to treat tinnitus fails in another clinical trial
One of the promising in-ear injections developed to treat acute tinnitus, Keyzilen, has failed another clinical trial. The drug developed by Auris Medical had first failed a clinical trial back in August 2016, not producing statistically significant changes in tinnitus loudness and tinnitus burden compared to a placebo. Preliminary results of a more recent test…
